Cook J A, Holbrook T W
Infect Immun. 1983 Jun;40(3):1038-43. doi: 10.1128/iai.40.3.1038-1043.1983.
The protective efficacy of glucan as an adjuvant with killed promastigotes of Leishmania donovani was compared with that of soluble or particulate fractions of the parasite. When these vaccine preparations were injected either intravenously or subcutaneously in CF-1 mice, glucan potentiated resistance against L. donovani infections as reflected by significant reductions in hepatic amastigote counts relative to infected control mice. The leishmanial antigens alone afforded no protection. Serum direct agglutination titers to leishmanial antigens were highest in all groups given the vaccine intravenously, whereas the delayed-type hypersensitivity response to the antigen was positive only in groups immunized subcutaneously with glucan as an adjuvant. Some index of protection and immune response against visceral infection with the parasite was seen in groups vaccinated with glucan and soluble antigens. However, the protection afforded by glucan and particulate antigens of L. donovani more closely paralleled the resistance of mice treated with glucan and unfractionated killed promastigotes. Further antigenic analysis of particulate fractions of L. donovani may optimize effective immunization when used with appropriate adjuvants, e.g., glucan.
将葡聚糖作为佐剂与杜氏利什曼原虫的灭活前鞭毛体联合使用的保护效果,与该寄生虫的可溶性或颗粒性组分的保护效果进行了比较。当这些疫苗制剂经静脉或皮下注射到CF-1小鼠体内时,葡聚糖增强了对杜氏利什曼原虫感染的抵抗力,这表现为相对于感染的对照小鼠,肝脏内无鞭毛体数量显著减少。单独的利什曼原虫抗原没有提供保护作用。在所有经静脉接种疫苗的组中,针对利什曼原虫抗原的血清直接凝集滴度最高,而对抗原的迟发型超敏反应仅在以葡聚糖作为佐剂皮下免疫的组中呈阳性。在用葡聚糖和可溶性抗原接种的组中,观察到了一些针对该寄生虫内脏感染的保护和免疫反应指标。然而,葡聚糖和杜氏利什曼原虫颗粒性抗原所提供的保护与用葡聚糖和未分级的灭活前鞭毛体处理的小鼠的抵抗力更为相似。对杜氏利什曼原虫颗粒性组分进行进一步的抗原分析,可能会在与合适的佐剂(如葡聚糖)联合使用时优化有效的免疫接种。